Skip to main content
microPublication Biology logoLink to microPublication Biology
. 2025 Aug 20;2025:10.17912/micropub.biology.001752. doi: 10.17912/micropub.biology.001752

Snapshot of Defense Systems in Multidrug Resistant Klebsiella pneumoniae

Tosin Yetunde Senbadejo 1, Samuel Ntiamoah Osei 1, Abiola Isawumi 1,§
Reviewed by: Anonymous
PMCID: PMC12409485  PMID: 40918426

Abstract

Bacterial defense mechanisms protect pathogens from host immunity, bacteriophages, and harsh environments. This study investigates defense systems in multidrug-resistant Klebsiella pneumoniae from Ghanaian hospital ICUs, focusing on CRISPR-Cas, restriction-modification (R-M), and toxin-antitoxin (TA) systems. Genomes of environmental (NS2) and clinical (PS4) strains were sequenced and analyzed using PADLOC, defensefinder, and TADB3.0. NS2 carries 12 defense systems, including CRISPR-Cas, while PS4 has five. Both possess diverse RM and TA systems. These strains, resistant to six antibiotic classes, encode clinically significant defense systems, suggesting microbial exchange between fomites and humans, potentially increasing infection risks in ICU environments requiring targeted surveillance.


Figure 1. Genomic Features and Defense Systems in Klebsiella pneumoniae .


Figure 1. Genomic Features and Defense Systems in
Klebsiella pneumoniae

(a) Comparative genome features of Klebsiella pneumoniae strains. NS2, the environmental strain has a bigger genome than the PS4, the clinical strain. (b) CRISPR-Cas identified in clinical isolate (PS4). (c) Defense systems including toxin-antitoxin systems, restriction and modification systems and other features in the Klebsiella pneumoniae strains. (d) The shared and unique Toxin-antitoxin (TA) types in the strains (e) Other defense systems in the strains.

Description

Klebsiella pneumoniae is an opportunistic pathogen implicated in hospital-acquired and community associated infections (Liang et al., 2022). As multidrug resistant pathogen, it contributes to public health challenges with consequent 22% to 72% annual mortality and morbidity rate (Poerio et al., 2022). Clinical and environmental K. pneumoniae shares antibiotic resistance (AMR) phenotypes, virulence and resistance genes (Rocha et al., 2022). Its severity and invasiveness is attributed to genome complexity and acquisition of factors facilitating persistence and evasion of host immune systems (de Sales et al., 2022). Some of these genomic factors are defense systems that play relevant roles in virulence and spread of multidrug resistance.

CRISPR-Cas, TAs, and restriction-modification (R-M) are defense systems involve in bacterial colonization, virulence regulation, biofilm formation, persistence, spread of genetic elements, and immunity against phages (Horesh et al., 2020). CRISPR-Cas systems in K. pneumoniae interfere with acquisition of phages and genetic elements that harbor AMR genes; therefore reduce AMR levels (Li et al., 2018). It has also been indicated that they can be explored for development of novel antimicrobial agents in the treatment of MDR K. pneumoniae infections (Xu et al., 2019).

Restriction and modification systems protect host bacterial cells from viruses and other bacteria (Bogdanova et al., 2008). R-M system is the most abundant and studied defense system in prokaryotes (Tesson et al., 2022). Type II R-M is the most abundant in bacterial genomes and in K. pneumoniae , KpnAI, KpnBI, Kpn2I are the most common (Chin, 2000). They provide the first line of immunity with restriction endonuclease (R) and methyltransferase (M). The R recognizes foreign DNA sequence and introduces double-stranded breaks around the recognition site while the M recognizes host DNA sequence and methylates to prevent cleavage and site recognition by R (Bogdanova et al., 2008). The type II systems are mostly plasmid-encoded for horizontal gene transfer (Rodic et al., 2017) and ensure bacterial persistence.

Toxin-antitoxin systems contribute to bacterial cell growth arrest and survival (Li et al., 2023). Also, it helps in genetic material maintenance, biofilm formation, resistance to stresses, virulence and pathogenesis (Kamruzzaman et al., 2021). TAs comprises a stable toxin and a labile antitoxin that can either be protein or RNA depending on the type. There are eight chromosomal or plasmid-mediated TAs (Type I - VIII) observed in bacterial genomes (Jurėnas et al., 2022). In Ghana, there is a paucity of data on defense systems in MDR K. pneumoniae , especially those isolated from Intensive Care Unit (ICU). It is therefore important to profile defense systems in the newly emerging MDR clinical and environmental K. pneumoniae , as AMR is increasingly becoming a burden in Ghana.

General Features and defense systems of multidrug resistant Klebsiella pneumoniae

Based on the genome sequencing, NS2 has 5,713,857 read sequences in 253 contigs with a GC content (57.1%), 5751 coding sequences and 94 RNAs while PS4 has 5,522,745 sequences in 126 contigs with a GC content (57.3%), 5413 coding sequences and 93 RNAs. Only 62.5% and 65.8% of the strains could be annotated with RAST and PROKKA v1.14.6 ( Figure 1A ). The strains have similar features with annotated reference K. pneumoniae . They have ANI values of 98 – 99% with those from database based on BLAST and MUMmer results. The genomes of the strains contain chromosome and plasmid-borne Type I, II and IV R-M systems. They are also abundant in the ‘pathogenicity islands’ indicating possible roles in pathogenicity and virulence. CRISPR-Cas systems including CRISPR-Cas Type I and subtype I-E were found in NS2 environmental isolate ( Figure 1B ). In similar study, Type I-E and subtype I-E were dominant in clinical isolates in association with higher virulence, acquisition of plasmids, other MGEs and MDR genes in K. pneumoniae (Alkompoz et al., 2023). NS2 as an environmental strain has a larger genome, more plasmids, hypothetical proteins and other mobile genetic elements including transposons and insertion sequences than PS4 ( Figure 1C ). Plasmids harbor genes that encode resistance and virulence. It has been indicated that K. pneumoniae resident on fomites (medical devices) harbor resistance markers, plasmids and stress-related genes (Rocha et al., 2022). The clinical isolate (PS4) carried MGEs encoding genes that could confer AMR, heavy metals tolerance and stress adaptation. In comparison with reference strain, NS2 and PS4 have 36 genes (14 systems) and 17 genes (6 systems) respectively. This might indicate the acquisition of extra defense systems from the environment or through selection pressure, especially at the ICU with significant reliance on antibiotics. CRISPR-Cas and R-M systems contribute to evolution and interactions between MGEs and bacterial hosts (Koonin & Makarova, 2017). There are more than thirty characterized and novel TAs. Three of the four NS2 plasmids have TAs (Supplementary). The frequency of Type II TAs are higher ( Figure 1D ), similar to previous study (Sberro et al., 2013). Majority of the TAs were localized in the chromosomes, contrary to what has been reported (Leplae et al., 2011). Also, some of the TAs were in the genomic island alongside R-M systems and other virulence genes.

To investigate potential horizontal gene transfer (HGT) between NS2 and PS4, both genomes were screened for mobile genetic elements and pairwise whole-genome alignments using stringent homology criteria of ≥95% nucleotide identity and ≥80% sequence coverage. Pairwise whole-genome alignment (dnadiff/nucmer; delta-filter -1) between NS2 and PS4 produced 269 collinear alignment blocks, collectively covering 4,993,204 bp of sequence, and identified 35,426 SNPs across aligned regions (~7.10 SNPs per kb). We then compared the plasmid and mobile element content of NS2 and PS4 to search for evidence of HGT. NS2 carries four plasmids and 12 additional MGEs, while PS4 carries one plasmid and 27 MGEs (transposons/IS). Despite genome-wide divergence, there were 12 MGEs that are highly conserved between the two strains, with percentage identities ranging from 97.3% to 100% and sequence coverages from 80% to 100%. The conserved MGEs include both insertion sequences (e.g., IS6100, IS5075, ISEc9, ISKpn12) and larger elements such as integrative conjugative elements (e.g., ICEEcoED1a-1). The high sequence identity and large alignment length indicate horizontal transfer events between the two strains. Comparing the predictions from PADLOC, DefenseFinder, and TADB 3.0 across all genomes, the discrepancies were minor and inconsequential. The tools produced consistent results in identifying the major defense systems, with greater than 90% agreement in system classification. For example, AbiEi/AbiEii was predicted by all three tools, whereas hok–sok was detected only by DefenseFinder and TADB. Minor discrepancies were observed, particularly in system subtyping and partial system predictions. For instance, DefenseFinder identified Gao systems absent from PADLOC results, likely due to differences in underlying HMM profiles and classification thresholds. TADB 3.0, which is specific for toxin–antitoxin systems, detected additional TA loci not reported by the other tools, likely because PADLOC and DefenseFinder focus on defense islands. These differences reflect variation in content of the database, detection thresholds, and annotation criteria, and these were considered in our interpretation of results because only unique genes and systems were selected from all tools.

Conclusion

This is the first study to characterize CRISPR-Cas, R-M and TAs in environmental and clinical K. pneumoniae strains from Ghanaian hospital ICUs. The strains have clinically relevant and comparable defense systems, thus indicating possibility of fomites-humans’ microbial exchange. This can also promote the spread of AMR, virulence genes and increase the risk of hospital acquired infections. The high levels of TAs and R-M in the genome of the strains might increase the expression of MGEs, AMR virulence genes and facilitate bacterial persistence under stress. These defense systems could serve as tools for prevention and control of MDR K. pneumoniae considering their abundance and contribution to virulence and pathogenicity.

Materials and Methods

Isolation, characterization and annotation of the bacterial strains

Klebsiella pneumoniae (NS2 and PS4) strains were obtained from ABISA Bacterial Culture Library at West African Centre of Cell Biology of Infectious Pathogens, University of Ghana. They were isolated from septicemia patients (PS4) and hospital ICU fomites (NS2). The gDNA was extracted using QIAGEN bacterial-DNA kit, genome sequenced on Illumina platform following library preparation. Rapid Annotation Subsystem Technology (RAST) was used for gene prediction and annotation of assembled sequences. Average Nucleotide Identity (ANI) was determined with JSpecies-WS. The nucleotide and protein sequences of the coding genes were used as data files for profiling the defense systems. The reference K. pneumoniae (HS11286) was downloaded from the NCBI database.

Identification of the defense systems, plasmids and resistance genes

Prokaryotic Antiviral Defense Locator (PADLOC) was used for profiling of defense systems. The genes encoding the defense systems were identified by matching protein sequences with curated database (Hidden Markov Models-HMM) with >700 families of defense systems related proteins. DefenseFinder and KEGG were used for confirmation. The PADLOC output was loaded into Geneious prime for visualization of CRISPR-Cas and R-M systems. TADB3.0 was used to predict different types of TA pairs. Existing sequences of experimentally validated TA-proteins were also inputted into TBLASTN and PSI-BLAST programs. Searches were performed against the annotated MDR K. pneumoniae genomes and plasmids with E-value >0.05. Mobile genetic element finder (MGE-Finder v1.0.3) was employed for identifying plasmids (and other MGE). Comprehensive Antibiotic Resistance Database (CARD) and Resistance finder (ResFinder) for resistance genes.

Acknowledgments

The authors would like to acknowledge the members and staff of the AMR Research Group (led by AI) at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) University of Ghana for technical support.

Funding Statement

Abiola Isawumi was supported by a World Bank ACE Seed Grant (ACE02-WACCBIP: Awandare). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

References

  1. Alkompoz Amany K., Hamed Samira M., Zaid Ahmed S. Abu, Almangour Thamer A., Al-Agamy Mohamed H., Aboshanab Khaled M. Correlation of CRISPR/Cas and Antimicrobial Resistance in Klebsiella pneumoniae Clinical Isolates Recovered from Patients in Egypt Compared to Global Strains. Microorganisms. 2023 Jul 30;11(8):1948–1948. doi: 10.3390/microorganisms11081948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bogdanova E, Djordjevic M, Papapanagiotou I, Heyduk T, Kneale G, Severinov K. 2008. Transcription regulation of the type II restriction-modification system AhdI. Nucleic Acids Research 36: 1429-1442. [DOI] [PMC free article] [PubMed]
  3. Chin V. 2000. Molecular Cloning and Analysis of the Modification Genes of the KpnBl Restriction- Modification System of Klebsiella pneumoniae Strain GM236. Loma Linda University Electronic Theses, Dissertations & Projects . https://scholarsrepository.llu.edu/etd/800
  4. de Sales Romário Oliveira, Leaden Laura, Migliorini Letícia Busato, Severino Patricia. A Comprehensive Genomic Analysis of the Emergent Klebsiella pneumoniae ST16 Lineage: Virulence, Antimicrobial Resistance and a Comparison with the Clinically Relevant ST11 Strain. Pathogens. 2022 Nov 22;11(12):1394–1394. doi: 10.3390/pathogens11121394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Horesh Gal, Fino Cinzia, Harms Alexander, Dorman Matthew J, Parts Leopold, Gerdes Kenn, Heinz Eva, Thomson Nicholas R. Type II and type IV toxin–antitoxin systems show different evolutionary patterns in the global Klebsiella pneumoniae population. Nucleic Acids Research. 2020 Mar 31;48(8):4357–4370. doi: 10.1093/nar/gkaa198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jurėnas Dukas, Fraikin Nathan, Goormaghtigh Frédéric, Van Melderen Laurence. Biology and evolution of bacterial toxin–antitoxin systems. Nature Reviews Microbiology. 2022 Jan 2;20(6):335–350. doi: 10.1038/s41579-021-00661-1. [DOI] [PubMed] [Google Scholar]
  7. Kamruzzaman Muhammad, Wu Alma Y., Iredell Jonathan R. Biological Functions of Type II Toxin-Antitoxin Systems in Bacteria. Microorganisms. 2021 Jun 11;9(6):1276–1276. doi: 10.3390/microorganisms9061276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koonin Eugene V., Makarova Kira S. Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back. Genome Biology and Evolution. 2017 Sep 18;9(10):2812–2825. doi: 10.1093/gbe/evx192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leplae Raphaël, Geeraerts Damien, Hallez Régis, Guglielmini Julien, Drèze Pierre, Van Melderen Laurence. Diversity of bacterial type II toxin–antitoxin systems: a comprehensive search and functional analysis of novel families. Nucleic Acids Research. 2011 Mar 21;39(13):5513–5525. doi: 10.1093/nar/gkr131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Li Meng, Guo Nannan, Song Gaoyu, Huang Yi, Wang Lecheng, Zhang Yani, Wang Tietao. Type II Toxin–Antitoxin Systems in Pseudomonas aeruginosa. Toxins. 2023 Feb 17;15(2):164–164. doi: 10.3390/toxins15020164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Li Hsin-Yu, Kao Cheng-Yen, Lin Wei-Hung, Zheng Po-Xing, Yan Jing-Jou, Wang Ming-Cheng, Teng Ching-Hao, Tseng Chin-Chung, Wu Jiunn-Jong. Characterization of CRISPR-Cas Systems in Clinical Klebsiella pneumoniae Isolates Uncovers Its Potential Association With Antibiotic Susceptibility. Frontiers in Microbiology. 2018 Jul 16;9 doi: 10.3389/fmicb.2018.01595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Liang Zihan, Wang Yiyao, Lai Yixiang, Zhang Jingyi, Yin Lanlan, Yu Xiang, Zhou Yongqin, Li Xinzhi, Song Yinhong. Host defense against the infection of Klebsiella pneumoniae: New strategy to kill the bacterium in the era of antibiotics? Frontiers in Cellular and Infection Microbiology. 2022 Nov 24;12 doi: 10.3389/fcimb.2022.1050396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Poerio Noemi, Olimpieri Tommaso, Henrici De Angelis Lucia, De Santis Federica, Thaller Maria Cristina, D’Andrea Marco Maria, Fraziano Maurizio. Fighting MDR-Klebsiella pneumoniae Infections by a Combined Host- and Pathogen-Directed Therapeutic Approach. Frontiers in Immunology. 2022 Feb 14;13 doi: 10.3389/fimmu.2022.835417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rocha Jaqueline, Henriques Isabel, Gomila Margarita, Manaia Célia M. Common and distinctive genomic features of Klebsiella pneumoniae thriving in the natural environment or in clinical settings. Scientific Reports. 2022 Jun 21;12(1) doi: 10.1038/s41598-022-14547-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rodic Andjela, Blagojevic Bojana, Zdobnov Evgeny, Djordjevic Magdalena, Djordjevic Marko. Understanding key features of bacterial restriction-modification systems through quantitative modeling. BMC Systems Biology. 2017 Feb 1;11(S1):1–15. doi: 10.1186/s12918-016-0377-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sberro Hila, Leavitt Azita, Kiro Ruth, Koh Eugene, Peleg Yoav, Qimron Udi, Sorek Rotem. Discovery of Functional Toxin/Antitoxin Systems in Bacteria by Shotgun Cloning. Molecular Cell. 2013 Apr 1;50(1):136–148. doi: 10.1016/j.molcel.2013.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tesson Florian, Hervé Alexandre, Mordret Ernest, Touchon Marie, d’Humières Camille, Cury Jean, Bernheim Aude. Systematic and quantitative view of the antiviral arsenal of prokaryotes. Nature Communications. 2022 May 10;13(1) doi: 10.1038/s41467-022-30269-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Xu Zeling, Li Ming, Li Yanran, Cao Huiluo, Miao Lu, Xu Zhaochao, Higuchi Yusuke, Yamasaki Seiji, Nishino Kunihiko, Woo Patrick C.Y., Xiang Hua, Yan Aixin. Native CRISPR-Cas-Mediated Genome Editing Enables Dissecting and Sensitizing Clinical Multidrug-Resistant P. aeruginosa. Cell Reports. 2019 Nov 1;29(6):1707–1717.e3. doi: 10.1016/j.celrep.2019.10.006. [DOI] [PubMed] [Google Scholar]

Articles from microPublication Biology are provided here courtesy of California Institute of Technology

RESOURCES